1. Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis
   Cong‑Ya Zhou et al, 2019, Oncology Letters CrossRef
2. CEACAM6’s Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6’s Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA
   Benediktas Kurlinkus et al, 2021, Life CrossRef
3. Overexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinoma
   Yazhou Wang et al, 2016, Biochemical and Biophysical Research Communications CrossRef
4. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer
   Guanchu Song et al, 2020, Experimental Cell Research CrossRef
5. Detection and Analysis of RNAs Expression Profile for Methylated Candidate Tumor Suppressor Genes in Nasopharyngeal Carcinoma
   Shuang Zhao et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
6. The emerging roles of CEACAM6 in human cancer (Review)
   Guanhua Wu et al, 2024, International Journal of Oncology CrossRef
7. Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients
   Thomas G. Biel et al, 2023, PLOS ONE CrossRef
8. Identification of the Key Genes and Pathways in Esophageal Carcinoma
   Peng Su et al, 2016, Gastroenterology Research and Practice CrossRef
9. MicroRNA-720 inhibits pancreatic cancer cell proliferation and invasion by directly targeting cyclin D1
   Yu Zhang et al, 2017, Molecular Medicine Reports CrossRef
10. Effect of CEACAM6 silencing on the biological behavior of human gallbladder cancer cells
    Chengming Tian et al, 2020, Oncology Letters CrossRef
11. MicroRNA‑584 directly targets CCND1 and inhibits cell proliferation and invasion in pancreatic cancer
    Gang Chen et al, 2018, Molecular Medicine Reports CrossRef